ACIU — AC Immune SA Cashflow Statement
0.000.00%
Last trade - 00:00
- $237.08m
- $127.13m
- CH₣14.80m
- 36
- 22
- 64
- 35
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 45.4 | -61.9 | -73 | -70.8 | -54.2 |
Depreciation | |||||
Non-Cash Items | 2.44 | 5.28 | -1.47 | 3.67 | 6.35 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 5.64 | -4.84 | 6.37 | -8.84 | -14.7 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 55.2 | -59.5 | -65.7 | -73.6 | -60.4 |
Capital Expenditures | -1.89 | -1.71 | -2.63 | -1.24 | -0.801 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -65 | 30 | -51 | 25 | 66.4 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -66.9 | 28.3 | -53.7 | 23.8 | 65.6 |
Financing Cash Flow Items | -0.51 | — | -0.006 | -0.784 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 49.6 | -0.803 | 40.7 | -1.35 | 43.3 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 37.1 | -32.7 | -78.7 | -50.6 | 46.9 |